- Home
- GDV vs ARWR Comparison
GDV vs ARWR Comparison
Compare GDV & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDV
- ARWR
- Stock Information
- Founded
- GDV 2003
- ARWR 2003
- Country
- GDV United States
- ARWR United States
- Employees
- GDV N/A
- ARWR N/A
- Industry
- GDV Investment Managers
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- GDV Finance
- ARWR Health Care
- Exchange
- GDV Nasdaq
- ARWR Nasdaq
- Market Cap
- GDV 2.2B
- ARWR 2.5B
- IPO Year
- GDV N/A
- ARWR 1993
- Fundamental
- Price
- GDV $26.88
- ARWR $29.08
- Analyst Decision
- GDV
- ARWR Strong Buy
- Analyst Count
- GDV 0
- ARWR 9
- Target Price
- GDV N/A
- ARWR $47.75
- AVG Volume (30 Days)
- GDV 186.0K
- ARWR 3.1M
- Earning Date
- GDV 01-01-0001
- ARWR 08-07-2025
- Dividend Yield
- GDV 5.81%
- ARWR N/A
- EPS Growth
- GDV N/A
- ARWR N/A
- EPS
- GDV N/A
- ARWR N/A
- Revenue
- GDV N/A
- ARWR $572,976,000.00
- Revenue This Year
- GDV N/A
- ARWR $22,306.37
- Revenue Next Year
- GDV N/A
- ARWR N/A
- P/E Ratio
- GDV N/A
- ARWR N/A
- Revenue Growth
- GDV N/A
- ARWR 2816.20
- 52 Week Low
- GDV $18.04
- ARWR $9.57
- 52 Week High
- GDV $23.00
- ARWR $29.34
- Technical
- Relative Strength Index (RSI)
- GDV 61.32
- ARWR 83.89
- Support Level
- GDV $26.72
- ARWR $21.61
- Resistance Level
- GDV $26.96
- ARWR $29.34
- Average True Range (ATR)
- GDV 0.22
- ARWR 1.30
- MACD
- GDV 0.01
- ARWR 0.84
- Stochastic Oscillator
- GDV 77.01
- ARWR 97.33
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.